RxDoctor Payments DataLook up a doctor →

Julianna Bergkamp

Adult Health · Wichita, KSNPI 1679704845

Payments from drug & device makers

$18,265in general payments, 2019–2025

Across 866 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Gilead$1K
  • AstraZeneca$1K
  • Bristol Myers Squibb$960
  • Pfizer$726
  • Seagen Inc.$650
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis103$2,566
Gilead33$1,174
AstraZeneca(2 entities)43$1,173
Bristol Myers Squibb62$960
Pfizer54$726
Seagen Inc.16$650
AbbVie39$631
Daiichi Sankyo Inc.32$629
Astellas Pharma US Inc31$508
E.r. Squibb & Sons, L.L.C.26$474
Merck25$452
Karyopharm Therapeutics Inc.4$407
CTI Biopharma Corp.2$406
GSK27$402
Johnson & Johnson16$399
Sanofi23$398
Amgen21$364
Tersera Therapeutics LLC15$356
Pharmacyclics LLC, An Abbvie Company17$327
Regeneron Healthcare Solutions, Inc.16$318
Bayer18$301
AVEO Pharmaceuticals, Inc.16$297
Epizyme, Inc.4$279
Takeda Pharmaceuticals U.S.A., Inc.13$230
Exelixis Inc.12$207
Rigel Pharmaceuticals, Inc.13$183
Genentech USA, Inc.12$174
Eisai Inc.9$170
Stemline Therapeutics Inc.10$166
Sobi, Inc10$159
Puma Biotechnology, Inc.4$154
Array Biopharma Inc11$144
Incyte Corporation9$135
Jazz Pharmaceuticals Inc.6$126
Heron Therapeutics, Inc.2$120
Myovant Sciences Inc.2$118
Sun Pharmaceutical Industries Inc.7$110
Coherus Oncology, Inc.7$107
Ipsen Biopharmaceuticals, Inc6$98
Servier Pharmaceuticals LLC5$87
Blueprint Medicines Corporation6$84
Taiho Oncology, Inc.4$78
Genmab U.S., Inc.4$77
Cardinal Health 110 LLC1$75
US Oncology Corporate, Inc.1$70
Springworks Therapeutics, Inc.4$68
Beigene USA, Inc.5$63
Foundation Medicine, Inc.3$62
Mylan Institutional Inc.4$62
Apellis Pharmaceuticals, Inc.3$58
Avyxa Pharma, LLC3$58
Mirati Therapeutics, Inc.3$55
Morphosys, US Inc.1$52
Pharmacosmos Therapeutics Inc.3$52
Sumitomo Pharma America, Inc.3$51
Recordati_rare_diseases_inc.3$48
Deciphera Pharmaceuticals Inc.2$41
Boehringer Ingelheim2$39
Octapharma USA, Inc.2$36
Dendreon Pharmaceuticals LLC2$36

How this compares

$18,265 in reported general payments places this provider in the 95th percentile of 155 adult health providers in Kansas.

See all adult health providers in Kansas

Medicare billing

Part B allowed, 2024
$188,698
Medicare patients
904
Services billed
5,584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →